• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性后期护理患者静脉血栓栓塞症的发生率及预测因素。一项前瞻性队列研究。

Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.

机构信息

Internal Medicine, Cà Foncello Hospital, Treviso, Italy.

出版信息

Thromb Haemost. 2010 Oct;104(4):734-40. doi: 10.1160/TH10-03-0169. Epub 2010 Jul 20.

DOI:10.1160/TH10-03-0169
PMID:20664897
Abstract

Few studies have addressed the topic of venous thromboembolism (VTE) in patients hospitalised in rehabilitation facilities. This patient population is rapidly growing, and data aimed to better define VTE risk in this setting are needed. Primary aim of this prospective observational study was to evaluate the frequency of symptomatic, objectively confirmed VTE in a cohort of unselected consecutive patients admitted to rehabilitation facilities, after medical diseases or surgery. Further objectives were to assess overall mortality, to identify risk factors for VTE and mortality, and to assess the attitude of physicians towards thromboprophylaxis. A total of 3,039 patients were included in the study, and the median duration of hospitalisation was 26 days. Seventy-two patients (2.4%) had symptomatic VTE. The median time to VTE from admission to the long-term care unit was 13 days. According to multivariable analysis, previous VTE (hazard ratio 5.67, 95% confidence interval 3.30-9.77) and cancer (hazard ratio 2.26, 95% confidence interval 1.36-3.75) were significantly associated to the occurrence of VTE. Overall in-hospital mortality was 15.1%. Age over 75 years, male gender, disability, cancer, and the absence of thromboprophylaxis were significantly associated to an increased risk of death (multivariable analysis). In-hospital antithrombotic prophylaxis was administered to 75.1% of patients, and low-molecular-weight heparin was the most widely used agent. According to our study, patients admitted to rehabilitation facilities remain at substantially increased risk for VTE. Because this applies to the majority of these patients, there is a great need for clinical trials assessing optimal prophylactic strategies.

摘要

很少有研究探讨过在康复机构住院的患者中的静脉血栓栓塞症(VTE)这一主题。该患者群体正在迅速增长,需要数据来更好地定义这种情况下的 VTE 风险。这项前瞻性观察研究的主要目的是评估在接受医疗疾病或手术后被送入康复设施的未经选择的连续患者队列中,症状性、客观证实的 VTE 的频率。进一步的目标是评估总体死亡率,确定 VTE 和死亡率的危险因素,并评估医生对血栓预防的态度。共有 3039 名患者纳入研究,住院中位数为 26 天。72 名患者(2.4%)出现症状性 VTE。从入院到长期护理病房的 VTE 中位时间为 13 天。根据多变量分析,既往 VTE(风险比 5.67,95%置信区间 3.30-9.77)和癌症(风险比 2.26,95%置信区间 1.36-3.75)与 VTE 的发生显著相关。总体院内死亡率为 15.1%。年龄大于 75 岁、男性、残疾、癌症和无血栓预防与死亡风险增加显著相关(多变量分析)。75.1%的患者接受了院内抗血栓预防治疗,低分子肝素是最广泛使用的药物。根据我们的研究,入住康复机构的患者仍然面临着显著增加的 VTE 风险。由于大多数患者都有这种情况,因此非常需要评估最佳预防策略的临床试验。

相似文献

1
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.急性后期护理患者静脉血栓栓塞症的发生率及预测因素。一项前瞻性队列研究。
Thromb Haemost. 2010 Oct;104(4):734-40. doi: 10.1160/TH10-03-0169. Epub 2010 Jul 20.
2
In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.内科住院患者的症状性静脉血栓栓塞及抗栓预防。一项多中心前瞻性研究的结果
Thromb Haemost. 2009 May;101(5):893-901.
3
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.急性脊髓损伤患者的短期和长期静脉血栓栓塞风险:一项前瞻性队列研究。
Thromb Haemost. 2013 Jan;109(1):34-8. doi: 10.1160/TH12-06-0390. Epub 2012 Dec 6.
4
Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.急性医疗机构静脉血栓栓塞风险与预防(ENDORSE 调查):外科患者的调查结果。
Ann Surg. 2010 Feb;251(2):330-8. doi: 10.1097/SLA.0b013e3181c0e58f.
5
Rates of venous thromboembolism occurrence in medical patients among the insured population.参保人群中医疗患者静脉血栓栓塞症发生率。
Thromb Haemost. 2009 Nov;102(5):951-7. doi: 10.1160/TH09-02-0073.
6
Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.高危外科和内科患者出院后使用低分子量肝素进行延长血栓预防:一项综述
Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002.
7
A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.对出院后发生静脉血栓栓塞症的患者进行血栓预防治疗的回顾性研究。
N Z Med J. 2010 Feb 19;123(1309):37-49.
8
Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.成年癌症患者群体中静脉血栓栓塞预防措施的回顾性评估。
J Oncol Pharm Pract. 2010 Mar;16(1):27-31. doi: 10.1177/1078155209104379. Epub 2009 Apr 28.
9
Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.贝米肝素在癌症手术中预防静脉血栓栓塞的最佳剂量:实践审核
Int J Surg. 2007 Apr;5(2):114-9. doi: 10.1016/j.ijsu.2006.07.005. Epub 2006 Nov 7.
10
Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.静脉血栓栓塞性疾病:在内外科重症监护病房患者中的一项观察性研究。
J Crit Care. 2000 Dec;15(4):127-32. doi: 10.1053/jcrc.2000.19224.

引用本文的文献

1
Risk, incidence and predictors of venous thromboembolism among patients attending the emergency department of tertiary care hospitals in Addis Ababa city, Ethiopia: a multicentre prospective study.埃塞俄比亚亚的斯亚贝巴市三级护理医院急诊科患者静脉血栓栓塞的风险、发生率及预测因素:一项多中心前瞻性研究
BMJ Open. 2025 Jan 14;15(1):e091364. doi: 10.1136/bmjopen-2024-091364.
2
The Use of Risk Scores for Thromboprophylaxis in Medically Ill Patients-Rationale and Design of the RICO trial.内科疾病患者血栓预防风险评分的应用——RICO试验的原理与设计
TH Open. 2024 Jan 12;8(1):e55-e60. doi: 10.1055/a-2209-4708. eCollection 2024 Jan.
3
Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers.
抗磷脂抗体携带者的风险评估与抗栓策略
Biomedicines. 2021 Jan 27;9(2):122. doi: 10.3390/biomedicines9020122.
4
Prevention of venous thromboembolism in acutely ill medical patients after the results of recent trials with the new oral anticoagulants.基于近期新型口服抗凝剂试验结果的急性内科疾病患者静脉血栓栓塞的预防
Intern Emerg Med. 2013 Dec;8(8):667-72. doi: 10.1007/s11739-013-0979-x. Epub 2013 Jul 16.
5
New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients.新型口服抗凝药物:在全膝关节置换术和住院内科患者的 III 期研究中预防静脉血栓栓塞症。
J Thromb Thrombolysis. 2013 Aug;36(2):141-8. doi: 10.1007/s11239-013-0955-3.
6
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.非外科患者的 VTE 预防:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e195S-e226S. doi: 10.1378/chest.11-2296.